Vitamin D in Dialysis Patients - Diagnostic and Therapeutic Management

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY

The goal of this observational study is to learn about the effects of cholecalciferol administration, according to guidelines for the general population, on laboratory parameters of Chronic Kidney Disease-Mineral and Bone Disorder in dialysis patients, depending of the attained levels of vitamin D (25OH)D). The main question it aims to answer is: How does cholecalciferol affect calcium and phosphate metabolism parameters depending on the achieved levels of 25(OH)D? Participants taking cholecalciferol as part of their regular medical care for CKD-MBD will have the laboratory result parameters observed for up to 4 years.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• CKD stage 5,dialysed patients with vitamin D deficiency or insufficiency (level of 25(OH)D \< 30 ng/mL)

Locations
Other Locations
Poland
Medical University of Gdansk
RECRUITING
Gdansk
Contact Information
Primary
Leszek Tylicki, Prof.
leszek.tylicki@gumed.edu.pl
+ 48 58 584 47 00
Backup
Agnieszka Tarasewicz, MD; PhD
ataras@gumed.edu.pl
Time Frame
Start Date: 2022-11-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 160
Treatments
25(OH)D < 30 ng/mL
Dialysed patients with vitamin D level (25(OH)D) \< 30 ng/mL administered cholecalciferol
25(OH)D 30 - 49.9 ng/mL
Dialysed patients with vitamin D level (25(OH)D) 30-49.9 ng/mL administered cholecalciferol
25(OH)D 50-80 ng/mL
Dialysed patients with vitamin D level (25(OH)D) 50-80 ng/mL administered cholecalciferol
Sponsors
Leads: Medical University of Gdansk

This content was sourced from clinicaltrials.gov